Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
Go back to Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation| (NASDAQ: ESLA) | Delayed: 0.93 -0.02 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.95 | 52 Week High | $ | |||
| Open | $0.94 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $ | |||
| Volume | 49,437 | |||||

